Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer
Open Access
- 10 June 2009
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 116 (8), 1062-1068
- https://doi.org/10.1111/j.1471-0528.2009.02214.x
Abstract
Objective To determine the morbidity of diaphragmatic peritonectomy. Design Prospective cohort study. Setting A Gynecology Department of a University Hospital. Population From 2005 to 2007, thirty‐seven consecutive patients underwent surgery for stage IIIC or IV ovarian cancer. Methods Patients were separated into a diaphragmatic surgery group (n = 18) and a control group (n = 19). Diaphragmatic surgery may consist of coagulation, stripping or muscle resection. Main outcome measures Postoperative course and outcome were analysed. Results Patients in group 1 (diaphragmatic surgery) underwent more intestinal resection (89% versus 37%, P = 0.01) and pelvic (94% versus 63%, P = 0.02) or para‐aortic lymphadenectomy (94% versus 53%, P = 0.04). Neither the mean estimated blood loss (960 ml versus 909 ml) nor the rates of intra‐operative blood transfusion (11 versus 9) were significantly different between the two groups. The mean operative time was higher in group 1 (480 minutes versus 316 minutes, P < 0.05). There were thirteen postoperative complications in group 1 and eight in group 2 (P = 0.065). In group 1, the main complication was pleural effusion (seven cases): four patients required secondary pleural drainage, two required only pleural puncture and one had both procedures. There were more complete cytoreduction in group 1 than in group 2 (89% versus 63%, P = 0.068). Conclusions Diaphragm peritonectomies and resections are an effective way to cytoreduce diaphragm carcinomatosis and increase the rate of optimal debulking surgery. Such procedures frequently result in pleural effusion, but with no long‐term morbidity.Keywords
This publication has 19 references indexed in Scilit:
- ACOG Practice Bulletin No. 84: Prevention of Deep Vein Thrombosis and Pulmonary EmbolismObstetrics & Gynecology, 2007
- Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?Gynecologic Oncology, 2007
- Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancerGynecologic Oncology, 2006
- Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancerGynecologic Oncology, 2006
- Relationship Between Time Interval From Primary Surgery to the Start of Taxane- Plus Platinum-Based Chemotherapy and Clinical Outcome of Patients With Advanced Epithelial Ovarian Cancer: Results of a Multicenter Retrospective Italian StudyJournal of Clinical Oncology, 2005
- Diaphragm resection for ovarian cancer: technique and short-term complicationsGynecologic Oncology, 2004
- Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approachGynecologic Oncology, 2004
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal ChemotherapyAnnals of Surgery, 1995
- Peritonectomy ProceduresAnnals of Surgery, 1995